Forte Steve has filed 19 insider transactions across 1 company since January 2023.
Most recent transaction: a disposition of 56786 shares of Repare Therapeutics Inc. ($RPTX) on January 28, 2026.
Activity breakdown: 0 open-market purchases and 6 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 28, 2026 | Repare Therapeutics Inc. | $RPTX | Forte Steve | EVP, CHIEF FINANCIAL OFFICER | D | Common Shares | 56786 | $0.00 | 0.0000 | 43,051,934 | 100.00% | 0.13% |
| Jan. 28, 2026 | Repare Therapeutics Inc. | $RPTX | Forte Steve | EVP, CHIEF FINANCIAL OFFICER | D | Employee Stock Option (right to buy) | 325800 | $0.00 | 0.0000 | 43,051,934 | 100.00% | 0.76% |
| Jan. 28, 2026 | Repare Therapeutics Inc. | $RPTX | Forte Steve | EVP, CHIEF FINANCIAL OFFICER | D | Employee Stock Option (right to buy) | 500000 | $0.00 | 0.0000 | 43,051,934 | 100.00% | 1.16% |
| Jan. 28, 2026 | Repare Therapeutics Inc. | $RPTX | Forte Steve | EVP, CHIEF FINANCIAL OFFICER | D | Employee Stock Option (right to buy) | 85000 | $0.00 | 0.0000 | 43,051,934 | 100.00% | 0.20% |
| Jan. 28, 2026 | Repare Therapeutics Inc. | $RPTX | Forte Steve | EVP, CHIEF FINANCIAL OFFICER | D | Employee Stock Option (right to buy) | 200000 | $0.00 | 0.0000 | 43,051,934 | 100.00% | 0.46% |
| April 2, 2025 | Repare Therapeutics Inc. | $RPTX | Forte Steve | EVP, CHIEF FINANCIAL OFFICER | A | Employee Stock Option (right to buy) | 500000 | $0.00 | 500,000.0000 | 42,411,085 | 9999.99% | 1.18% |
| March 12, 2025 | Repare Therapeutics Inc. | $RPTX | Forte Steve | EVP, CHIEF FINANCIAL OFFICER | S | Common Shares | 6884 | $1.14 | 54,786.0000 | 42,411,085 | 11.16% | 0.02% |
| March 4, 2025 | Repare Therapeutics Inc. | $RPTX | Forte Steve | EVP, CHIEF FINANCIAL OFFICER | A | Employee Stock Option (right to buy) | 85000 | $0.00 | 85,000.0000 | 42,411,085 | 9999.99% | 0.20% |
| March 4, 2025 | Repare Therapeutics Inc. | $RPTX | Forte Steve | EVP, CHIEF FINANCIAL OFFICER | A | Common Shares | 14000 | $0.00 | 61,670.0000 | 42,411,085 | 29.37% | 0.03% |
| March 4, 2025 | Repare Therapeutics Inc. | $RPTX | Forte Steve | EVP, CHIEF FINANCIAL OFFICER | A | Employee Stock Option (right to buy) | 200000 | $0.00 | 200,000.0000 | 42,411,085 | 9999.99% | 0.47% |
| April 1, 2024 | Repare Therapeutics Inc. | $RPTX | Forte Steve | EVP, CHIEF FINANCIAL OFFICER | S | Common Shares | 789 | $4.61 | 44,775.0000 | 42,093,293 | 1.73% | 0.00% |
| March 28, 2024 | Repare Therapeutics Inc. | $RPTX | Forte Steve | EVP, CHIEF FINANCIAL OFFICER | S | Common Shares | 825 | $4.62 | 45,564.0000 | 42,093,293 | 1.78% | 0.00% |
| March 27, 2024 | Repare Therapeutics Inc. | $RPTX | Forte Steve | EVP, CHIEF FINANCIAL OFFICER | S | Common Shares | 825 | $4.62 | 42,212.0000 | 42,093,293 | 1.92% | 0.00% |
| March 26, 2024 | Repare Therapeutics Inc. | $RPTX | Forte Steve | EVP, CHIEF FINANCIAL OFFICER | S | Common Shares | 825 | $4.60 | 43,037.0000 | 42,093,293 | 1.88% | 0.00% |
| March 25, 2024 | Repare Therapeutics Inc. | $RPTX | Forte Steve | EVP, CHIEF FINANCIAL OFFICER | S | Common Shares | 825 | $4.79 | 43,862.0000 | 42,093,293 | 1.85% | 0.00% |
| March 1, 2024 | Repare Therapeutics Inc. | $RPTX | Forte Steve | EVP, CHIEF FINANCIAL OFFICER | A | Common Shares | 14000 | $0.00 | 44,687.0000 | 42,093,293 | 45.62% | 0.03% |
| March 1, 2024 | Repare Therapeutics Inc. | $RPTX | Forte Steve | EVP, CHIEF FINANCIAL OFFICER | A | Employee Stock Option (right to buy) | 85000 | $0.00 | 85,000.0000 | 42,093,293 | 9999.99% | 0.20% |
| Jan. 30, 2023 | Repare Therapeutics Inc. | $RPTX | Forte Steve | EVP, Chief Financial Officer | A | Employee Stock Option (right to buy) | 111050 | $0.00 | 111,050.0000 | 0 | 9999.99% | 0.00% |
| Jan. 30, 2023 | Repare Therapeutics Inc. | $RPTX | Forte Steve | EVP, Chief Financial Officer | A | Common Shares | 24530 | $0.00 | 30,687.0000 | 0 | 398.41% | 0.00% |